Market revenue in 2023 | USD 21.5 million |
Market revenue in 2030 | USD 30.6 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Microbiology & sterility testing |
Fastest growing segment | Biocompatibility Tests |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing, Package Validation |
Key market players worldwide | SGS AG, Eurofins Scientific SE, Pace Analytical Services, Intertek Group PLC, Wuxi AppTec Co Ltd, Sotera Health Co Ordinary Shares, Charles River Laboratories International Inc, NAMSA |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to preclinical medical device testing services market will help companies and investors design strategic landscapes.
Microbiology & sterility testing was the largest segment with a revenue share of 34.42% in 2023. Horizon Databook has segmented the Malaysia preclinical medical device testing services market based on biocompatibility tests, chemistry test, microbiology & sterility testing, package validation covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Malaysia preclinical medical device testing services market, including forecasts for subscribers. This country databook contains high-level insights into Malaysia preclinical medical device testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account